At AgeRejuvenation the blend is delivered under medical supervision after an evaluation, never as a one-size-fits-all package
This prevents accidental double-dosing while maintaining consistent weekly intervals
This program cultivates our commitment to delivering tailored, impactful health solutions that significantly enhance employee well-being and reduce healthcare costs. The global market for anti-obesity medications could grow to $100 billion by 2030, according to Goldman Sachs Research
Across phase III trials of GLP-1 receptor agonist and multi-hormone receptor modulator obesity drugs in adults with overweight or obesity, the magnitude of blood pressure-lowering was closely associated with the degree of weight loss, highlighting the clinically relevant yet often underappreciated blood pressure-lowering potential of these drugs, the authors concluded
What About the Research
Karen Thampoe, Owner and Medical Director, ensures that all treatments are guided by medical expertise and patient-focused care